Variant report
Variant | nsv527252 |
---|---|
Chromosome Location | chr7:11544610-11547284 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6943841 | chr7:11544610-11544611 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs564808015 | chr7:11544635-11544636 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116995966 | chr7:11544640-11544641 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564729101 | chr7:11544641-11544642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533428743 | chr7:11544664-11544665 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs6944001 | chr7:11544687-11544688 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs55928740 | chr7:11544736-11544737 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs577591114 | chr7:11544755-11544756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs76199984 | chr7:11544792-11544793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575249632 | chr7:11544808-11544809 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190298685 | chr7:11544813-11544814 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6944156 | chr7:11544819-11544820 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs150694001 | chr7:11544857-11544858 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs372637920 | chr7:11544891-11544892 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577151324 | chr7:11544892-11544893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs116739575 | chr7:11544901-11544902 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs180699519 | chr7:11544929-11544930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186087208 | chr7:11544976-11544977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572736804 | chr7:11544978-11544979 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541425988 | chr7:11545004-11545005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561745018 | chr7:11545032-11545033 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs545102834 | chr7:11545044-11545045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572023892 | chr7:11545059-11545060 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs200864043 | chr7:11545073-11545074 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs541154067 | chr7:11545076-11545077 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200969278 | chr7:11545088-11545089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs148095009 | chr7:11545113-11545114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191945713 | chr7:11545148-11545149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533393391 | chr7:11545236-11545237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs74551768 | chr7:11545289-11545290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs139946576 | chr7:11545304-11545305 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563065914 | chr7:11545314-11545315 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529615693 | chr7:11545336-11545337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549089711 | chr7:11545348-11545349 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576745594 | chr7:11545362-11545363 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs377501819 | chr7:11545407-11545408 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs57906196 | chr7:11545417-11545418 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs111412721 | chr7:11545440-11545441 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs184210227 | chr7:11545484-11545485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs534801660 | chr7:11545503-11545504 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs76241885 | chr7:11545506-11545507 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs370305815 | chr7:11545508-11545509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200948569 | chr7:11545509-11545510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185805123 | chr7:11545525-11545526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539604004 | chr7:11545543-11545544 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs556409856 | chr7:11545546-11545547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs569937576 | chr7:11545563-11545564 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11764309 | chr7:11545566-11545567 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs190606236 | chr7:11545581-11545582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572046026 | chr7:11545643-11545644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Autism | 22495309 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Melanoma | 20877625 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:11544000-11547400 | Weak transcription | H1 Cell Line | embryonic stem cell |
2 | chr7:11544400-11547400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr7:11544400-11549000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr7:11544800-11545000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr7:11544800-11545800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr7:11544800-11549000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr7:11545000-11547400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr7:11545200-11545600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr7:11545600-11546600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
10 | chr7:11545800-11546200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
11 | chr7:11546200-11548400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr7:11546600-11546800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr7:11546600-11546800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr7:11546800-11547200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
15 | chr7:11546800-11547400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
16 | chr7:11547000-11548000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr7:11547200-11547400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |